Resistance to Antimycotics: Role of Calcineurin and Protein Kinases

Resistance to Antimycotics: Role of Calcineurin and Protein Kinases

Saved in:

Bibliographic Details
Main Author:	A. V. Nikitin
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/211
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mechanisms of Nephrotoxic Action of Immunodepressants, Calcineurine Inhibitors
by: A. V. Nikitin
Published: (2020-05-01)

Antibacterial and Antimycotic Properties of Modiﬁed Carbon Sorbents
by: V. T. Dolgikh, et al.
Published: (2023-02-01)

Modulating the Antifungal Activity of Antimycotic Drugs with Farnesol
by: N. P. Sachivkina, et al.
Published: (2021-11-01)

Antimicrobial and antimycotic photodynamic therapy (review of literature)
by: D. Yu. Semyonov, et al.
Published: (2021-04-01)

Identification and determination of resistance to antimycotic factors in yeast clinical isolates during respiratory diseases
by: Irina S. Andreeva, et al.
Published: (2024-12-01)

Antimycotic Activity of the Bacillus subtilis 534 Strain - Foundations of Probiotic Sporobakterin
by: N. I. Gabrielyan, et al.
Published: (2020-05-01)

On the interchangeability of calcineurine inhibitors
by: K. E. Zatolochina, et al.
Published: (2018-02-01)

Antibacterial and Antimycotic Properties of Granular Carbon Sorbents Modified With Lactic Acid Oligomers
by: L. G. P'yanova, et al.
Published: (2020-05-01)

Role of Calcineurin Inhibitors in the Management of Atopic Dermatitis in Children
by: Kamilla E. Efendieva, et al.
Published: (2023-12-01)

ANTIMYCOTIC ACTIVITY OF ACTIVATED ZINC PYRITHIONE IN RELATION TO MALASSEZIA IN PATIENTS WITH ATOPIC DERMATITIS
by: E.V. Golysheva, et al.
Published: (2010-11-01)

The role of calcineurin inhibitors in the progression of hepatocellular carcinoma after liver transplantation
by: O. D. Olisov, et al.
Published: (2022-09-01)

Synthesis and antimycotic activity of new derivatives of imidazo[1,2-a]pyrimidines
by: Dmitriy Yu. Vandyshev, et al.
Published: (2024-11-01)

Analysis of the prevalence and sensitivity to antimycotic drugs of C. albicans strains in Bukovina during 2019–2023
by: O. O. Blinder, et al.
Published: (2025-04-01)

Study of base influence on the active pharmaceutical ingredients releasing from combined ointments with antimycotic action
by: V. V. Luc, et al.
Published: (2018-03-01)

Aqueous spice extracts as alternative antimycotics to control highly drug resistant extensive biofilm forming clinical isolates of Candida albicans.
by: Bindu Sadanandan, et al.
Published: (2023-01-01)

Antimycotic activity of Myrtus communis L. towards Candida spp. from clinical isolates
by: Sara Cannas, et al.
Published: (2013-03-01)

Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia
by: Wada A, et al.
Published: (2016-07-01)

Role of calcineurin and ionotropic glutamate receptors in Alzheimer's disease: A systematic review
by: Awgichew Behaile Teklemariam, et al.
Published: (2025-06-01)

Dosing of Antimycotic Treatment in Sepsis–Induced Liver Dysfunction by Functional Liver Testing with LiMAx®
by: Carmen Kirchner, et al.
Published: (2019-01-01)

HR-LCMS based metabolites profiling, pharmacognostic study, and antimycotic activity of leaves of Ruellia asperula
by: Arshu Patel, et al.
Published: (2025-02-01)

Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus
by: N. Yu. Nikishina, et al.
Published: (2025-06-01)

The role of protein kinase C and PI3-kinase in the mechanism of the cardioprotective effect of remote ischemic postconditioning
by: A. V. Mukhomedzyanov, et al.
Published: (2022-01-01)

Approaches to correction of immunosuppressive therapy in chronic nephrotoxicity of calcineurin inhibitors
by: E. S. Stolyarevich, et al.
Published: (2018-08-01)

The calcineurin pathway regulates extreme thermotolerance, cell membrane and wall integrity, antifungal resistance, and virulence in Candida auris.
by: Hyunjin Cha, et al.
Published: (2025-07-01)

Host-induced gene silencing targeting the calcineurin of Fusarium fujikuroi to enhance resistance against rice bakanae disease
by: Yi-Hsuan Hou, et al.
Published: (2025-04-01)

Chemical composition and antimycotic potential of basil, rosemary, clove and cinnamon essential oils against Trichophyton rubrum and Trichophyton mentagrophytes
by: Patrícia Abreu Pereira, et al.
Published: (2024-12-01)

Calcineurin as a marker of myocardial hypertrophy in children with valvular congenital heart diseases
by: A. V. Kamenshchyk, et al.
Published: (2015-06-01)

Analysis of early use of everolimus with low-dose calcineurin inhibitors in kidney transplant recipient
by: I. G. Kim, et al.
Published: (2019-10-01)

WCN25-2809 TO STUDY CALCINEURIN INHIBITOR SPARING STRATEGIES IN PATIENTS WITH STAEROID RESISTANT AND STEROID DEPENDENT NEPHROTIC SYNDROME
by: Mahak Joshi, et al.
Published: (2025-02-01)

A retrospective study of calcineurin inhibitors in the treatment of idiopathic membranous nephropathy
by: CUI Lin-lin, et al.
Published: (2015-01-01)

PHARMACOGENETICS OF CALCINEURIN INHIBITORS IN HEMATOPOIETIC CELL TRANSPLANTATION: A SYSTEMATIC REVIEW
by: LC Costa-Junior, et al.
Published: (2024-10-01)

Stable and destabilized GFP reporters to monitor calcineurin activity in Saccharomyces cerevisiae
by: Jutta Diessl, et al.
Published: (2020-02-01)

Heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against Scedosporium prolificans via induction of apoptosis
by: Fazal Shirazi, et al.
Published: (2014-06-01)

Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer
by: Xuankai Liao, et al.
Published: (2025-08-01)

The role of calmodulin and calmodulin-dependent protein kinases in the pathogenesis of atherosclerosis
by: Mei-Fang Chen
Published: (2022-01-01)

Calcineurin-mediated regulation of growth-associated protein 43 is essential for neurite and synapse formation and protects against α-synuclein-induced degeneration
by: Ekaterina Grebenik, et al.
Published: (2025-04-01)

Calcineurin–NFAT signalling in myeloid leucocytes: new prospects and pitfalls in immunosuppressive therapy
by: Kamila Bendickova, et al.
Published: (2017-06-01)

Factors associated with chronic calcineurin inhibitor nephrotoxicity in children with minimal-change disease
by: Bei Jin, et al.
Published: (2025-12-01)

CO confers neuroprotection via activating the PERK-calcineurin pathway and inhibiting necroptosis
by: Jeongmin Park, et al.
Published: (2025-05-01)

Meta-analysis of calcineurin inhibitor vs.cyclophosphamide in the treatment of idiopathic membranous nephropathy
by: XIE Guang-liang, et al.
Published: (2015-01-01)